RVPH Reviva Pharmaceuticals Holdings
$0.53▲ +6.98%
Healthcare
Other
Volume 22.6K
Avg Volume (10D) 29.2K
Key Metrics & Fundamentals
Market Cap
$7.01M
P/E Ratio
–
Div Yield
–%
52W Range
0.26 - 17.20
% vs 50 MA
6.51%
% vs 200 MA
-82.02%
RSI-14
54.4
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.14
Free Cash Flow
-$2.12M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.44M
COGS
–
Operating Exp
$2.62M
Operating Income
-$2.62M
EBIT
-$2.62M
Pretax Income
-$2.45M
Net Income
-$2.45M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News

Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 12, 2026 8:29 PM
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
GlobeNewswire · Jun 26, 2026 12:35 PM
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
GlobeNewswire · Jun 23, 2026 12:35 PM
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th
GlobeNewswire · Jun 23, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RVPH's money flow as a full page
Social Sentiment
Avg +0.70 · 3 posts
NewsDiscussionRVPH - news on upcoming FDA approval
r/investing · Nov 16, 2025
The post highlights a pre-NDA meeting, a strong signal for FDA engagement and potential NDA filing, indicating significant bullish sentiment.
very_positive
+1.00
RVPH - Upcoming FDA approval
r/stocks · Nov 16, 2025
The discussion of FDA approval and cash reserves suggests a cautiously optimistic view of the stock.
positive
+0.30
DDNewsDiscussionPriceTargetRVHP. This biotech company has high potential to make us rich!!
r/investing · Jul 15, 2025
The post expresses a 'strong buy' opinion and highlights positive aspects of the company's drug pipeline and results. High potential for returns is stated.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.